Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Mouse Anti-Human CD61-FITC (PM6/13)

Cat. No.:
9470-02
FITC Anti-Human CD61 antibody for use in flow cytometry, immunocytochemistry, and western blot assays.
$187.00
Size Price (USD) Quantity
100 tests $187.00
More Information
Clone PM6/13
Isotype Mouse (BALB/c) IgG1κ
Isotype Control Mouse IgG1-FITC (15H6)
Specificity Human CD61
Alternative Names Integrin β3, GPIIIa
Description CD61 is the integrin β3 subunit, a 110 kDa transmembrane glycoprotein expressed on platelets, megakaryocytes, and endothelial cells. Integrin β3 associates with gpIIb (CD41) to form the CD41/CD61 complex that mediates platelet adhesion and aggregation. CD61 also associates with CD51 to form the αVβ3 vitronectin receptor.
Immunogen Human platelet plasma membrane
Conjugate FITC (Fluorescein)
Buffer Formulation Phosphate buffered saline containing < 0.1% sodium azide
Clonality Monoclonal
Concentration Lot specific
Volume 1.0 mL
Recommended Storage 2-8°C; Avoid exposure to light
Applications Flow Cytometry – Quality tested 2,5-7
Immunocytochemistry – Reported in literature 2
Immunoprecipitation – Reported in literature 1
Western Blot-Non-Reducing – Reported in literature 1
Blocking – Reported in literature 1,3,4
Adhesion – Reported in literature 4
ELISA – Reported in literature 3

RRID Number AB_2796813
Gene ID 3690 (Human)
Gene ID Symbol ITGB3 (Human)
Gene ID Aliases BDPLT16; BDPLT2; CD61; GP3A; GPIIIa; GT
UniProt ID P05106 (Human)
UniProt Name ITB3_HUMAN (Human)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view


Need help with this product?
or call 800.722.2255
  1. 1. Patel Y, Rahman S, Siddiqua A, Wilkinson JM, Kakkar VV, Authi KS. Functional characterization of PM6/13, a β3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets. Thromb Haemost. 1998;79:177-85. (Immunogen, IP, WB-NR, Block)
  2. 2. Wilkinson JM, Sankar AA, Currie MJ. The expression of adhesion receptors and cytoskeletal proteins in the megakaryoblastic cell line CHRF-288-11. In: Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, et al, editors. Leukocyte Typing V: White Cell Differentiation Antigens. Oxford: Oxford University Press; 1995. p. 1210-13. (FC, ICC)
  3. 3. Komiya E, Sato H, Watanabe N, Ise M, Higashi S, Miyagi Y, et al. Angiomodulin, a marker of cancer vasculature, is upregulated by vascular endothelial growth factor and increases vascular permeability as a ligand of integrin αvβ3. Cancer Med. 2014;3:537-49. (ELISA, Block)
  4. 4. Gu Y, Nilsson K, Eng H, Ekblom M. Association of extracellular matrix proteins fibulin-1 and fibulin-2 with fibronectin in bone marrow stroma. Br J Haematol. 2000;109:305-13. (Block, Adhesion)
  5. 5. Hapke S, Kessler H, de Prada NA, Benge A, Schmitt M, Lengyel E. Integrin αvβ3/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells. J Biol Chem. 2001;276:26340-8. (FC)
  6. 6. Lester EA, Babensee JE. Proinflammatory phenotype of endothelial cells after coculture with biomaterial-treated blood cells. J Biomed Mater Res A. 2003;64:397-410. (FC)
  7. 7. Rose SL, Babensee JE. Procoagulant phenotype of endothelial cells after coculture with biomaterial-treated blood cells. J Biomed Mater Res A. 2005;72:269-78. (FC)
See All References